Cardlytics (CDLX) Tops Q3 EPS by 26c, Misses on Revenue

Cardlytics (NASDAQ: CDLX) reported Q3 EPS of ($0.07), $0.26 better than the analyst estimate of ($0.33). Revenue for the quarter came in at $52 million versus the consensus estimate of $67.33 million.

For earnings history and earnings-related data on Cardlytics (CDLX) click here.

You May Also Be Interested In

• Apple suing OpenAI over alleged misappropriation of trade secrets
• JPMorgan Upgrades Largan Precision Co Ltd. (3008:TT) to Overweight
• HSBC Starts Parkway Life REIT (PREIT:SP) (PRKWF) at Buy